MedTrace Logo

Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease

NCT04966767 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2021-07-19

No results posted yet for this study

Summary

This is a prospective, multicenter, real-world, registry study, which aims to observe the intermediate and long-term efficacy of different endovascular treatments for TASC C\&D aortoiliac occlusive disease.

Conditions

  • Peripheral Arterial Disease

Sponsors & Collaborators

  • RenJi Hospital

    collaborator OTHER

  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER

  • Chengdu University of Traditional Chinese Medicine

    collaborator OTHER

  • Xuanwu Hospital, Beijing

    collaborator OTHER

  • First People's Hospital of Hangzhou

    collaborator OTHER

  • Qingdao Hiser Medical Group

    collaborator OTHER

  • Second Affiliated Hospital of Soochow University

    collaborator OTHER

  • Huashan Hospital

    collaborator OTHER

  • Shanghai Zhongshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2027-07-31
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04966767 on ClinicalTrials.gov